Delivery Order SPE2DB24D3013-SPE2DB25FFNTX
Award Date 7/28/25
Potential Completion Date 7/29/25
Potential Value $4.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injectors in 0.5 mL quantities, with a contract ceiling value of $32,050.85. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and...
- The Defense Logistics Agency awarded a delivery order valued at $10,048.41 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injectors on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based pharmaceutical product used in diabetes and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $30,103.40 for Zepbound 7.5 mg/0.5 mL pens on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. Zepbound is a semaglutide-based medication indicated for weight management and represents part of the pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $38,515.12 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injections on July 18, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The delivery is scheduled for completion by July 21, 2025, with performance at the...
- The Defense Logistics Agency awarded a $16,923.31 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injectors on July 31, 2025, with completion scheduled for August 1, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026....
- The Defense Logistics Agency awarded a $6,188.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pen injectors on July 28, 2025, with completion expected by July 29, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that supports comprehensive pharmaceutical and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,973.24 on July 31, 2025, for the supply of Zepbound 5 mg/0.5 mL pens (0.5 mL). This is a firm fixed-price delivery order with no set-aside designation, issued as a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with completion scheduled for August 1, 2025. Zepbound, a semaglutide...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a ceiling value of $1,525.20. This firm fixed-price delivery order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement under the company's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $6,750.31 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $6,970.68 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injectors. The contract is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and will be fulfilled at the contractor's Conshohocken, Pennsylvania facility. This award represents a non-set-aside competitive procurement, demonstrating AmerisourceBergen's continued capability to meet federal pharmaceutical...